
Eric Olson
Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1673, 1623 |
| Total Applications | 1758 |
| Issued Applications | 971 |
| Pending Applications | 175 |
| Abandoned Applications | 632 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19290410
[patent_doc_number] => 12029749
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Methods of treatment and maintenance therapy for bladder cancer using gemcitabine
[patent_app_type] => utility
[patent_app_number] => 17/010648
[patent_app_country] => US
[patent_app_date] => 2020-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 26169
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17010648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/010648 | Methods of treatment and maintenance therapy for bladder cancer using gemcitabine | Sep 1, 2020 | Issued |
Array
(
[id] => 18244492
[patent_doc_number] => 20230076803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => COMPOUND AND DRUG CONJUGATE, AND PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/639063
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17639063
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/639063 | COMPOUND AND DRUG CONJUGATE, AND PREPARATION METHOD AND USE THEREOF | Aug 27, 2020 | Pending |
Array
(
[id] => 18051605
[patent_doc_number] => 11524976
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-13
[patent_title] => Oligonucleotide synthesizer
[patent_app_type] => utility
[patent_app_number] => 17/005854
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7274
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17005854
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/005854 | Oligonucleotide synthesizer | Aug 27, 2020 | Issued |
Array
(
[id] => 17850588
[patent_doc_number] => 20220280629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => ANTIMICROBIAL VACCINE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/638732
[patent_app_country] => US
[patent_app_date] => 2020-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16934
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638732
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638732 | ANTIMICROBIAL VACCINE COMPOSITIONS | Aug 26, 2020 | Pending |
Array
(
[id] => 16898105
[patent_doc_number] => 20210177021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => METHOD OF PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 16/999483
[patent_app_country] => US
[patent_app_date] => 2020-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16999483
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/999483 | METHOD OF PRODUCTION | Aug 20, 2020 | Abandoned |
Array
(
[id] => 16483840
[patent_doc_number] => 20200377441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => METHODS OF PROTECTING AN ORGAN USING TETRAHYDROCURCUMIN AND PHOSPHATIDYLCHOLINE
[patent_app_type] => utility
[patent_app_number] => 16/997255
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997255
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997255 | METHODS OF PROTECTING AN ORGAN USING TETRAHYDROCURCUMIN AND PHOSPHATIDYLCHOLINE | Aug 18, 2020 | Abandoned |
Array
(
[id] => 17913224
[patent_doc_number] => 20220315619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => (HETERO)ARYL-METHYL-THIO-BETA-D-GALACTOPYRANOSIDE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/633895
[patent_app_country] => US
[patent_app_date] => 2020-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28510
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633895
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/633895 | (Hetero)aryl-methyl-thio-beta-D-galactopyranoside derivatives | Aug 6, 2020 | Issued |
Array
(
[id] => 20213566
[patent_doc_number] => 12410208
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => (2-acetamidyl)thio-beta-D-galactopyranoside derivatives
[patent_app_type] => utility
[patent_app_number] => 17/633941
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22999
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633941
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/633941 | (2-acetamidyl)thio-beta-D-galactopyranoside derivatives | Aug 5, 2020 | Issued |
Array
(
[id] => 17697071
[patent_doc_number] => 11370781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Combination therapy for treating cancer
[patent_app_type] => utility
[patent_app_number] => 16/985404
[patent_app_country] => US
[patent_app_date] => 2020-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 38794
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 291
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16985404
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/985404 | Combination therapy for treating cancer | Aug 4, 2020 | Issued |
Array
(
[id] => 16569091
[patent_doc_number] => 20210008097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => Compositions Comprising Galactose-Pronged Polysaccharides
[patent_app_type] => utility
[patent_app_number] => 16/983760
[patent_app_country] => US
[patent_app_date] => 2020-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16983760
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/983760 | Compositions Comprising Galactose-Pronged Polysaccharides | Aug 2, 2020 | Abandoned |
Array
(
[id] => 17620149
[patent_doc_number] => 11339187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Process for the preparation of GalNAc oligonucleotide conjugates
[patent_app_type] => utility
[patent_app_number] => 16/939849
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5916
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16939849
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/939849 | Process for the preparation of GalNAc oligonucleotide conjugates | Jul 26, 2020 | Issued |
Array
(
[id] => 16437071
[patent_doc_number] => 20200354397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => PHOSPHORAMIDITE SYNTHONES FOR THE SYNTHESIS OF SELF-NEUTRALIZING OLIGONUCLEOTIDE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/940039
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16940039
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/940039 | Phosphoramidite synthones for the synthesis of self-neutralizing oligonucleotide compounds | Jul 26, 2020 | Issued |
Array
(
[id] => 16619976
[patent_doc_number] => 20210038629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => COMPOUNDS AND METHODS FOR MODULATING GFAP
[patent_app_type] => utility
[patent_app_number] => 16/938826
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938826
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/938826 | Compounds and methods for modulating GFAP | Jul 23, 2020 | Issued |
Array
(
[id] => 16569083
[patent_doc_number] => 20210008089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER
[patent_app_type] => utility
[patent_app_number] => 16/929690
[patent_app_country] => US
[patent_app_date] => 2020-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16929690
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/929690 | COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER | Jul 14, 2020 | Abandoned |
Array
(
[id] => 16791669
[patent_doc_number] => 20210121486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/921562
[patent_app_country] => US
[patent_app_date] => 2020-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50325
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16921562
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/921562 | ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE | Jul 5, 2020 | Abandoned |
Array
(
[id] => 17774917
[patent_doc_number] => 20220241266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => COMPOSITIONS AND METHODS USING TRIGONELLINE AND HIGH PROTEIN FOR PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLE
[patent_app_type] => utility
[patent_app_number] => 17/597343
[patent_app_country] => US
[patent_app_date] => 2020-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597343
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/597343 | COMPOSITIONS AND METHODS USING TRIGONELLINE AND HIGH PROTEIN FOR PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLE | Jul 2, 2020 | Abandoned |
Array
(
[id] => 17774917
[patent_doc_number] => 20220241266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => COMPOSITIONS AND METHODS USING TRIGONELLINE AND HIGH PROTEIN FOR PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLE
[patent_app_type] => utility
[patent_app_number] => 17/597343
[patent_app_country] => US
[patent_app_date] => 2020-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597343
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/597343 | COMPOSITIONS AND METHODS USING TRIGONELLINE AND HIGH PROTEIN FOR PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLE | Jul 2, 2020 | Abandoned |
Array
(
[id] => 16359347
[patent_doc_number] => 20200316098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => TERNARY MIXTURES OF 6'-SL, LNnT and LST c
[patent_app_type] => utility
[patent_app_number] => 16/913590
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16913590
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/913590 | TERNARY MIXTURES OF 6'-SL, LNnT and LST c | Jun 25, 2020 | Abandoned |
Array
(
[id] => 16523727
[patent_doc_number] => 20200397807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => NICOTINYL RIBOSIDE COMPOUNDS AND THEIR USES
[patent_app_type] => utility
[patent_app_number] => 16/904270
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904270
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/904270 | NICOTINYL RIBOSIDE COMPOUNDS AND THEIR USES | Jun 16, 2020 | Abandoned |
Array
(
[id] => 17761483
[patent_doc_number] => 20220235095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => SAPONIN PURIFICATION
[patent_app_type] => utility
[patent_app_number] => 17/615254
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615254
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/615254 | SAPONIN PURIFICATION | Jun 2, 2020 | Pending |